Genetic testing in Italy is characterized by a strong emphasis on clinical validity and ethical integration within the national health system (Servizio Sanitario Nazionale). The country has a long history of excellence in genetics, particularly in the study of rare diseases and hereditary cancers. Italian laboratories are at the forefront of utilizing Whole Exome Sequencing (WES) to provide definitive diagnoses for patients with complex, undiagnosed conditions. This clinical focus ensures that genetic insights are delivered within a framework of professional counseling and medical supervision.
A significant area of focus in Italy is Non-Invasive Prenatal Testing (NIPT). This technology, which analyzes cell-free fetal DNA from the mother's blood, has become a preferred screening method for chromosomal abnormalities such as Down syndrome. Its high accuracy and safety compared to invasive procedures like amniocentesis have led to its widespread adoption. Public health discussions often revolve around the inclusion of NIPT in the basic…